2021
DOI: 10.1186/s12889-021-11177-x
|View full text |Cite
|
Sign up to set email alerts
|

Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020

Abstract: Background Availability of SARS-CoV-2 testing in the United States (U.S.) has fluctuated through the course of the COVID-19 pandemic, including in the U.S. state of Illinois. Despite substantial ramp-up in test volume, access to SARS-CoV-2 testing remains limited, heterogeneous, and insufficient to control spread. Methods We compared SARS-CoV-2 testing rates across geographic regions, over time, and by demographic characteristics (i.e., age and rac… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 26 publications
2
17
0
Order By: Relevance
“…Test positivity rates (TPR) for Black and Hispanic/Latinx populations were much higher than in the White population at this time (Fig. 3 B), suggesting relatively insufficient testing in Black and Hispanic/Latinx demographics despite their slightly higher rate of per capita testing [ 16 ]. TPR exceeded 35% in all Hispanic/Latinx populations over 10 and Black populations over 18 in interval 1, compared with peak values of around 20% in White.…”
Section: Resultsmentioning
confidence: 99%
“…Test positivity rates (TPR) for Black and Hispanic/Latinx populations were much higher than in the White population at this time (Fig. 3 B), suggesting relatively insufficient testing in Black and Hispanic/Latinx demographics despite their slightly higher rate of per capita testing [ 16 ]. TPR exceeded 35% in all Hispanic/Latinx populations over 10 and Black populations over 18 in interval 1, compared with peak values of around 20% in White.…”
Section: Resultsmentioning
confidence: 99%
“…Many different approaches to high throughput testing have been deployed in support of such comprehensive testing 4,[15][16][17] , but these are expensive and difficult to scale and maintain. There is also a risk that such resource-intensive testing programs will perpetuate inequalities in the distribution of COVID-19 testing access [18][19][20][21][22][23] .…”
Section: Introductionmentioning
confidence: 99%
“…Incident cases, the fraction of diagnostic tests that return a positive result (test positivity rate, TPR), or any other metric based on diagnostic testing in the general population is subject to bias due to fluctuating access to, availability of, and demand for diagnostic testing. These factors vary across time, geography, age, and racial and ethnic groups, and the data needed to control for these biases is often unavailable [1,[13][14][15][16][17]. The timeliness of data can also be hampered by long turn-around-times and delays in vendors' reporting of test results to health agencies [14].…”
Section: Introductionmentioning
confidence: 99%